eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Astellas Pharma Ltd

3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 14/04/2011
SPC Cardene SR 30 and 45mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   13-Dec-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



In section 7 the address of the MAH, Astellas Pharma Ltd., has been updated following a move to new premises.  This entails the address changing from Lovett House, Lovett Road, Staines, TW18 3AZ, United Kingdom to 3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH, United Kingdom.

 

In section 10 the last revision date of the text has been revised to correspond with this move to new premises as detailed in Section 7.  This date is updated to 13th December 2010.

Updated on 19/04/2010 and displayed until 14/04/2011
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   08-Mar-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.1 - List of Excipients:
 
            "Starch" has changed to "Maize Starch"
 
 
Details of the printing ink have been added:
 

            Printing ink:  Opacode Red S-1-25082

Shellac

Iron oxide, red (E172)

n-Butyl alcohol NF

Propylene glycol (E1520)

Purified water

Ammonia solution

Industrial methylated spirit

Isopropyl alcohol

            Printing Ink:  TekPrint  SW-1102 Red Ink

Shellac

Dehydrated alcohol

Isopropyl alcohol

Butyl alcohol

Propylene glycol

Strong ammonia solution

Iron oxide, red (E172)

Potassium hydroxide

Purified water

Updated on 28/06/2006 and displayed until 19/04/2010
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 6. 4 - Special Precautions for Storage
Date of revision of text on the SPC:   06/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

4.4     Excipient warning regarding lactose added.
 
4.5    Change from the BAN to INN name for cyclosporine.
 
6.4    Change to the storage conditions wording.
Updated on 09/01/2006 and displayed until 28/06/2006
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 06/01/2006 and displayed until 09/01/2006
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 22/07/2004 and displayed until 06/01/2006
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
  • Change to section 6.1 - List of Excipients
Updated on 30/12/2003 and displayed until 22/07/2004
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 10 (date of (partial) revision of the text
Updated on 25/09/2003 and displayed until 30/12/2003
Reasons for adding or updating:
  • Change to joint SPC covering all presentations
Updated on 24/09/2002 and displayed until 25/09/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 06/08/2002 and displayed until 24/09/2002
Reasons for adding or updating:
  • Addition of Legal Category
Updated on 07/08/2001 and displayed until 06/08/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/02/2001 and displayed until 07/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 25/02/2000 and displayed until 13/02/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 25/02/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   nicardipine hydrochloride